For IP professionals
This is the portal for professionals working in the field of intellectual property. Here you'll find direct access to all necessary resources.
Quick links
News
01.07.2024 | Law and policy, Copyright
New directive for the supervision of the collective rights management organisations
...more
New Swiss Biotech Report shows exceptional sector performance
The latest edition of the Swiss Biotech Report highlights projects and companies that were part of the Swiss response to the COVID-19 pandemic, as the life science industry applied its R&D and manufacturing capabilities to deliver effective solutions in record time.
While the spotlight was on Covid-related projects (such as cloning of the virus, diagnostic development or vaccine production) Switzerland and Swiss biotech companies did not lose sight of other unmet medical needs and continued to invest heavily to expand their R&D and manufacturing infrastructure. Investors contributed new funds at record levels to advance the promising pipeline of the Swiss biotech hub. In total, R&D investments increased by 10% to CHF 2.2B.
Key findings in the 2021 Swiss Biotech Report
Swiss biotechs raised a total of CHF 3.44B – their best year ever. CHF 2.7B were invested in public companies including ADC Therapeutics from Lausanne with a CHF 470M (IPO & follow on), CRISPR Therapeutics (CHF 940M), Idorsia (CHF 866M), Molecular Partners (CHF 80M), and Basilea (CHF 125M). The biggest portion of the private capital was raised by VectivBio Holding AG (CHF 135M), SOPHiA Genetics (CHF 100M), and the newly founded company Noema Pharma (CHF 54M).
The Swiss biotech industry generated revenues of CHF 4.5B, compared to CHF 4.8B in 2019. This drop in revenues was mainly due to favorable one-time events in 2019 which didn’t recur in 2020. Nevertheless, biotechs selling marketed products/services continued to increase their revenues.
The latest edition of the Swiss Biotech Report launched by the Swiss Biotech Association in conjunction with EY and eight other partner organizations inclucing Swiss Federal Institute for Intellecutal Property provides analysis of funding, M&A activity and collaborations.
News
20.08.2024 | IPI, Dienstleistungen - OnlineServices, Dienstleistungen - Datenbanken und Verzeichnisse
Swissreg is to be completely modernised
...more
01.07.2024 | Law and policy, Copyright
New directive for the supervision of the collective rights management organisations
...more
27.05.2024 | Patents, Media release, Law and policy, Conference
New international treaty on intellectual property, genetic resources and associated traditional knowledge adopted
...more
Events
19.01.2023 | Law and policy, Event
Conference on Intellectual Property & Sustainability at the University of Geneva
...more